Back to mobile site

More on ANIX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (6/22/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Anixa Biosciences (NQ:ANIX)
Delayed: 2.91 +0.22 (8.18%)
Prev. Close $2.69  
Open$2.76 
52 Wk High$ 
52 Wk Low$ 
Day High$2.94 
Day Low$2.58 
P/E N/A  
EPS$ 
Volume600,837 


Jun 17, 2026 11:21 AM Form 4 Anixa Biosciences Inc For: Jun 16 Filed by: Titterton Lewis H jr
Jun 16, 2026 09:00 AM Form 4 Anixa Biosciences Inc For: Jun 12 Filed by: KUMAR AMIT
Jun 12, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
Jun 11, 2026 09:05 AM Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
Jun 10, 2026 04:16 PM Form 10-Q Anixa Biosciences Inc For: Apr 30
Jun 1, 2026 09:00 AM Anixa receives Canadian patent allowance for ovarian cancer vaccine
Jun 1, 2026 09:00 AM Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
May 11, 2026 11:48 AM /C O R R E C T I O N -- Anixa Biosciences, Inc./
May 11, 2026 08:55 AM Anixa Biosciences reports patient survival data from cancer therapy trial
May 11, 2026 08:55 AM Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy
View All Articles

Entities mentioned with ANIX

View All Entities